Broad neutralization of SARS-related viruses by human monoclonal antibodiesAnna Z. Wec, Laura M. Walker, Ching‐Lin Hsieh et al.|Science|2020Cited by 645
Prolonged evolution of the human B cell response to SARS-CoV-2 infectionMrunal Sakharkar, Laura M. Walker, C. Garrett Rappazzo et al.|Science Immunology|2021Cited by 201
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape MutantsDenise Haslwanter, Rohit K. Jangra, M. Eugenia Dieterle et al.|mBio|2021Cited by 61
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z. Wec, Laura M. Walker, Daniel Wrapp et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 28
A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutantsDenise Haslwanter, Rohit K. Jangra, M. Eugenia Dieterle et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4